<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37890487</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-3791</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>Cell reports. Medicine</Title><ISOAbbreviation>Cell Rep Med</ISOAbbreviation></Journal><ArticleTitle>Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID.</ArticleTitle><Pagination><StartPage>101254</StartPage><MedlinePgn>101254</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101254</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xcrm.2023.101254</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2666-3791(23)00431-7</ELocationID><Abstract><AbstractText>The post-acute sequelae of COVID-19 (PASC), also known as long COVID, is often associated with debilitating symptoms and adverse multisystem consequences. We obtain plasma samples from 117 individuals during and 6&#xa0;months following their acute phase of infection to comprehensively profile and assess changes in cytokines, proteome, and metabolome. Network analysis reveals sustained inflammatory response, platelet degranulation, and cellular activation during convalescence accompanied by dysregulation in arginine biosynthesis, methionine metabolism, taurine metabolism, and tricarboxylic acid (TCA) cycle processes. Furthermore, we develop a prognostic model composed of 20 molecules involved in regulating T&#xa0;cell exhaustion and energy metabolism that can reliably predict adverse clinical outcomes following discharge from acute infection with 83% accuracy and an area under the curve (AUC) of 0.96. Our study reveals pertinent biological processes during convalescence that differ from acute infection, and it supports the development of specific therapies and biomarkers for patients suffering from long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kaiming</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, AB, Canada; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khoramjoo</LastName><ForeName>Mobin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada; Department of Physiology, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinivasan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Chemical and Materials Engineering, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Paul M K</ForeName><Initials>PMK</Initials><AffiliationInfo><Affiliation>Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandal</LastName><ForeName>Rupasri</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Metabolomics Innovation Center, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, AB, Canada; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sligl</LastName><ForeName>Wendy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Alberta, Edmonton, AB, Canada; Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Maria B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penninger</LastName><ForeName>Josef M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada; Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borchers</LastName><ForeName>Christoph H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada; Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wishart</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>The Metabolomics Innovation Center, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Vinay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Chemical and Materials Engineering, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oudit</LastName><ForeName>Gavin Y</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, AB, Canada; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada; Department of Physiology, University of Alberta, Edmonton, AB, Canada. Electronic address: gavin.oudit@ualberta.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 EY025383</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep Med</MedlineTA><NlmUniqueID>101766894</NlmUniqueID><ISSNLinking>2666-3791</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003289" MajorTopicYN="N">Convalescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095028" MajorTopicYN="N">Multiomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">phenotyping</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>28</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37890487</ArticleId><ArticleId IdType="pmc">PMC10694626</ArticleId><ArticleId IdType="doi">10.1016/j.xcrm.2023.101254</ArticleId><ArticleId IdType="pii">S2666-3791(23)00431-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lazarus J.V., Romero D., Kopka C.J., Karim S.A., Abu-Raddad L.J., Almeida G., Baptista-Leite R., Barocas J.A., Barreto M.L., Bar-Yam Y., et al. A multinational Delphi consensus to end the COVID-19 public health threat. Nature. 2022;611:332&#x2013;345. doi: 10.1038/s41586-022-05398-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05398-2</ArticleId><ArticleId IdType="pmc">PMC9646517</ArticleId><ArticleId IdType="pubmed">36329272</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 2023;29:2347&#x2013;2357. doi: 10.1038/s41591-023-02521-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Gheblawi M., Nikhanj A., Munan M., MacIntyre E., O'Neil C., Poglitsch M., Colombo D., Del Nonno F., Kassiri Z., et al. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries. Hypertension. 2022;79:365&#x2013;378. doi: 10.1161/HYPERTENSIONAHA.121.18295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.121.18295</ArticleId><ArticleId IdType="pubmed">34844421</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit G.Y., Wang K., Viveiros A., Kellner M.J., Penninger J.M. Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic. Cell. 2023;186:906&#x2013;922. doi: 10.1016/j.cell.2023.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.01.039</ArticleId><ArticleId IdType="pmc">PMC9892333</ArticleId><ArticleId IdType="pubmed">36787743</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 2021;12:6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F., Catalan P., Rodriguez-Grande C., Adan J., Rodriguez-Gonzalez C., Mu&#xf1;oz P., Aldamiz T., Diez C., Perez L., Fanciulli C., et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J.&#xa0;Clin. Invest. 2022;132 doi: 10.1172/JCI161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1beta, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Reports. Medicine. 2022;3 doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8&#xa0;months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford S.E., Stellmach V., Murphy-Ullrich J.E., Ribeiro S.M., Lawler J., Hynes R.O., Boivin G.P., Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in&#xa0;vivo. Cell. 1998;93:1159&#x2013;1170. doi: 10.1016/s0092-8674(00)81460-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)81460-9</ArticleId><ArticleId IdType="pubmed">9657149</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T., Yoshinaga S.K., Shibue K., Mak T.W. Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19. Cell Death Differ. 2021;28:3199&#x2013;3213. doi: 10.1038/s41418-021-00892-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00892-y</ArticleId><ArticleId IdType="pmc">PMC8522258</ArticleId><ArticleId IdType="pubmed">34663907</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T., Perez-Potti A., Rivera-Ballesteros O., Str&#xe5;lin K., Gorin J.B., Olsson A., Llewellyn-Lacey S., Kamal H., Bogdanovic G., Muschiol S., et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020;183:158&#x2013;168.e14. doi: 10.1016/j.cell.2020.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7427556</ArticleId><ArticleId IdType="pubmed">32979941</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., Donatelli J., Thanh C., Takahashi S., Hakim J., et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36 doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciaudone A., Corkrey H., Humphries F., Koupenova M. Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond. Circ. Res. 2023;132:1272&#x2013;1289. doi: 10.1161/CIRCRESAHA.122.321930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321930</ArticleId><ArticleId IdType="pmc">PMC10171305</ArticleId><ArticleId IdType="pubmed">37167360</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Yi X., Sun Y., Bi X., Du J., Zhang C., Quan S., Zhang F., Sun R., Qian L., et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020;182:59&#x2013;72.e15. doi: 10.1016/j.cell.2020.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindelar M., Stancliffe E., Schwaiger-Haber M., Anbukumar D.S., Adkins-Travis K., Goss C.W., O'Halloran J.A., Mudd P.A., Liu W.C., Albrecht R.A., et al. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep. Med. 2021;2 doi: 10.1016/j.xcrm.2021.100369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100369</ArticleId><ArticleId IdType="pmc">PMC8292035</ArticleId><ArticleId IdType="pubmed">34308390</ArticleId></ArticleIdList></Reference><Reference><Citation>Overmyer K.A., Shishkova E., Miller I.J., Balnis J., Bernstein M.N., Peters-Clarke T.M., Meyer J.G., Quan Q., Muehlbauer L.K., Trujillo E.A., et al. Large-Scale Multi-omic Analysis of COVID-19 Severity. Cell Syst. 2021;12:23&#x2013;40.e7. doi: 10.1016/j.cels.2020.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.10.003</ArticleId><ArticleId IdType="pmc">PMC7543711</ArticleId><ArticleId IdType="pubmed">33096026</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W.R., Parikh C.R. Biomarkers of Acute and Chronic Kidney Disease. Annu. Rev. Physiol. 2019;81:309&#x2013;333. doi: 10.1146/annurev-physiol-020518-114605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-020518-114605</ArticleId><ArticleId IdType="pmc">PMC7879424</ArticleId><ArticleId IdType="pubmed">30742783</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wan Y., Zuo T., Yeoh Y.K., Liu Q., Zhang L., Zhan H., Lu W., Xu W., Lui G.C.Y., et al. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19. Gastroenterology. 2022;162:548&#x2013;561.e4. doi: 10.1053/j.gastro.2021.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G.F., Ren S., Tang R.Y., Xu C., Zhou J.Q., Lin S.M., Feng Y., Yang Q.H., Hu J.M., Yang J.C. Antidepressant effect of taurine in chronic unpredictable mild stress-induced depressive rats. Sci. Rep. 2017;7:4989. doi: 10.1038/s41598-017-05051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05051-3</ArticleId><ArticleId IdType="pmc">PMC5504064</ArticleId><ArticleId IdType="pubmed">28694433</ArticleId></ArticleIdList></Reference><Reference><Citation>Michely J., Eldar E., Martin I.M., Dolan R.J. A mechanistic account of serotonin's impact on mood. Nat. Commun. 2020;11:2335. doi: 10.1038/s41467-020-16090-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16090-2</ArticleId><ArticleId IdType="pmc">PMC7214430</ArticleId><ArticleId IdType="pubmed">32393738</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.W., Lam S.M., Fan X., Cao W.J., Wang S.Y., Tian H., Chua G.H., Zhang C., Meng F.P., Xu Z., et al. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell Metabol. 2020;32:188&#x2013;202.e5. doi: 10.1016/j.cmet.2020.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7311890</ArticleId><ArticleId IdType="pubmed">32610096</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohuslavov&#xe1; R., Kol&#xe1;&#x159; F., Kuthanov&#xe1; L., Neck&#xe1;&#x159; J., Tichop&#xe1;d A., Pavlinkova G. Gene expression profiling of sex differences in HIF1-dependent adaptive cardiac responses to chronic hypoxia. J.&#xa0;Appl. Physiol. 2010;109:1195&#x2013;1202. doi: 10.1152/japplphysiol.00366.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00366.2010</ArticleId><ArticleId IdType="pubmed">20634361</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemet I., Saha P.P., Gupta N., Zhu W., Romano K.A., Skye S.M., Cajka T., Mohan M.L., Li L., Wu Y., et al. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. Cell. 2020;180:862&#x2013;877.e22. doi: 10.1016/j.cell.2020.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.016</ArticleId><ArticleId IdType="pmc">PMC7402401</ArticleId><ArticleId IdType="pubmed">32142679</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W., Gregory J.C., Org E., Buffa J.A., Gupta N., Wang Z., Li L., Fu X., Wu Y., Mehrabian M., et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell. 2016;165:111&#x2013;124. doi: 10.1016/j.cell.2016.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.02.011</ArticleId><ArticleId IdType="pmc">PMC4862743</ArticleId><ArticleId IdType="pubmed">26972052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Lau R.I., Liu Q., Su Q., Chan F.K.L., Ng S.C. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 2023;20:323&#x2013;337. doi: 10.1038/s41575-022-00698-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00698-4</ArticleId><ArticleId IdType="pmc">PMC9589856</ArticleId><ArticleId IdType="pubmed">36271144</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlister F.A., Nabipoor M., Chu A., Lee D.S., Saxinger L., Bakal J.A., CORONA Collaboration The impact of shifting demographics, variants of concern and vaccination on outcomes during the first 3 COVID-19 waves in Alberta and Ontario: a retrospective cohort study. CMAJ Open. 2022;10:E400&#x2013;E408. doi: 10.9778/cmajo.20210323.</Citation><ArticleIdList><ArticleId IdType="doi">10.9778/cmajo.20210323</ArticleId><ArticleId IdType="pmc">PMC9121845</ArticleId><ArticleId IdType="pubmed">35473827</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., Lone N.I., Leavy O.C., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., Patel U. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J.&#xa0;Med. Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Lu P., Dhodapkar R.M., Gehlhausen J.R., Tabachnikova A., Tabacof L., Malik A.A., Kamath K., et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv. 2022 doi: 10.1101/2022.08.09.22278592. Preprint at.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Gon&#xe7;alves R., Campos M.M., Palhinha L., Azevedo-Quintanilha I.G., Abud Mendes M., Ramos Temerozo J., Toledo-Mendes J., Rosado-de-Castro P.H., Bozza F.A., Souza Rodrigues R., et al. Persisting Platelet Activation and Hyperactivity in COVID-19 Survivors. Circ. Res. 2022;131:944&#x2013;947. doi: 10.1161/CIRCRESAHA.122.321659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.321659</ArticleId><ArticleId IdType="pmc">PMC9645447</ArticleId><ArticleId IdType="pubmed">36268747</ArticleId></ArticleIdList></Reference><Reference><Citation>Minutti C.M., Modak R.V., Macdonald F., Li F., Smyth D.J., Dorward D.A., Blair N., Husovsky C., Muir A., Giampazolias E., et al. A Macrophage-Pericyte Axis Directs Tissue Restoration via Amphiregulin-Induced Transforming Growth Factor Beta Activation. Immunity. 2019;50:645&#x2013;654.e6. doi: 10.1016/j.immuni.2019.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.01.008</ArticleId><ArticleId IdType="pmc">PMC6436929</ArticleId><ArticleId IdType="pubmed">30770250</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun H.J., Coutavas E., Pine A.B., Lee A.I., Yu V.L., Shallow M.K., Giovacchini C.X., Mathews A.M., Stephenson B., Que L.G., et al. Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection. JCI Insight. 2021;6 doi: 10.1172/jci.insight.148476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148476</ArticleId><ArticleId IdType="pmc">PMC8410030</ArticleId><ArticleId IdType="pubmed">34111030</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataraman T., Frieman M.B. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antivir. Res. 2017;143:142&#x2013;150. doi: 10.1016/j.antiviral.2017.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.03.022</ArticleId><ArticleId IdType="pmc">PMC5507769</ArticleId><ArticleId IdType="pubmed">28390872</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibellini L., De Biasi S., Paolini A., Borella R., Boraldi F., Mattioli M., Lo Tartaro D., Fidanza L., Caro-Maldonado A., Meschiari M., et al. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol. Med. 2020;12 doi: 10.15252/emmm.202013001.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202013001</ArticleId><ArticleId IdType="pmc">PMC7645870</ArticleId><ArticleId IdType="pubmed">33078545</ArticleId></ArticleIdList></Reference><Reference><Citation>Domizio J.D., Gulen M.F., Saidoune F., Thacker V.V., Yatim A., Sharma K., Nass T., Guenova E., Schaller M., Conrad C., et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature. 2022;603:145&#x2013;151. doi: 10.1038/s41586-022-04421-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04421-w</ArticleId><ArticleId IdType="pmc">PMC8891013</ArticleId><ArticleId IdType="pubmed">35045565</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittle J., Molinger J., MacLeod D., Haines K., Wischmeyer P.E., LEEP-COVID Study Group Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19. Crit. Care. 2020;24:581. doi: 10.1186/s13054-020-03286-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03286-7</ArticleId><ArticleId IdType="pmc">PMC7521195</ArticleId><ArticleId IdType="pubmed">32988390</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux R.K., Naviaux J.C., Li K., Bright A.T., Alaynick W.A., Wang L., Baxter A., Nathan N., Anderson W., Gordon E. Metabolic features of chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2016;113:E5472&#x2013;E5480. doi: 10.1073/pnas.1607571113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607571113</ArticleId><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez Y., Li X., Liu G., Bin P., Yan W., M&#xe1;s D., Valdivi&#xe9; M., Hu C.A.A., Ren W., Yin Y. The role of methionine on metabolism, oxidative stress, and diseases. Amino Acids. 2017;49:2091&#x2013;2098. doi: 10.1007/s00726-017-2494-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-017-2494-2</ArticleId><ArticleId IdType="pubmed">28929442</ArticleId></ArticleIdList></Reference><Reference><Citation>Liesa M., Shirihai O.S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metabol. 2013;17:491&#x2013;506. doi: 10.1016/j.cmet.2013.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.03.002</ArticleId><ArticleId IdType="pmc">PMC5967396</ArticleId><ArticleId IdType="pubmed">23562075</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterfield D.A., Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 2019;20:148&#x2013;160. doi: 10.1038/s41583-019-0132-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0132-6</ArticleId><ArticleId IdType="pmc">PMC9382875</ArticleId><ArticleId IdType="pubmed">30737462</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrikaki M., Lee J.D., Solomon I.H., Slack F.J. Severe COVID-19 is associated with molecular signatures of aging in the human brain. Nat. Aging. 2022;2:1130&#x2013;1137. doi: 10.1038/s43587-022-00321-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00321-w</ArticleId><ArticleId IdType="pubmed">37118539</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L., Benigni A., Casiraghi F., Ng L.F.P., Renia L., Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat. Rev. Nephrol. 2021;17:46&#x2013;64. doi: 10.1038/s41581-020-00357-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-020-00357-4</ArticleId><ArticleId IdType="pmc">PMC7570423</ArticleId><ArticleId IdType="pubmed">33077917</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H.T., Anderson A.C., Tan W.G., West E.E., Ha S.J., Araki K., Freeman G.J., Kuchroo V.K., Ahmed R. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA. 2010;107:14733&#x2013;14738. doi: 10.1073/pnas.1009731107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1009731107</ArticleId><ArticleId IdType="pmc">PMC2930455</ArticleId><ArticleId IdType="pubmed">20679213</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C., Sakuishi K., Xiao S., Sun Z., Zaghouani S., Gu G., Wang C., Tan D.J., Wu C., Rangachari M., et al. An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction. Nat. Commun. 2015;6:6072. doi: 10.1038/ncomms7072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7072</ArticleId><ArticleId IdType="pmc">PMC4311884</ArticleId><ArticleId IdType="pubmed">25614966</ArticleId></ArticleIdList></Reference><Reference><Citation>Chihara N., Madi A., Kondo T., Zhang H., Acharya N., Singer M., Nyman J., Marjanovic N.D., Kowalczyk M.S., Wang C., et al. Induction and transcriptional regulation of the co-inhibitory gene module in T&#xa0;cells. Nature. 2018;558:454&#x2013;459. doi: 10.1038/s41586-018-0206-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0206-z</ArticleId><ArticleId IdType="pmc">PMC6130914</ArticleId><ArticleId IdType="pubmed">29899446</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Li D., Cao G., Shi Q., Zhu J., Zhang M., Cheng H., Wen Q., Xu H., Zhu L., et al. IL-27 signalling promotes adipocyte thermogenesis and energy expenditure. Nature. 2021;600:314&#x2013;318. doi: 10.1038/s41586-021-04127-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04127-5</ArticleId><ArticleId IdType="pubmed">34819664</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen C., Li F., Zhang L., Duan Y., Guo Q., Wang W., He S., Li J., Yin Y. Taurine is Involved in Energy Metabolism in Muscles, Adipose Tissue, and the Liver. Mol. Nutr. Food Res. 2019;63 doi: 10.1002/mnfr.201800536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201800536</ArticleId><ArticleId IdType="pubmed">30251429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T.J., Ngo D., Psychogios N., Dejam A., Larson M.G., Vasan R.S., Ghorbani A., O'Sullivan J., Cheng S., Rhee E.P., et al. 2-Aminoadipic acid is a biomarker for diabetes risk. J.&#xa0;Clin. Invest. 2013;123:4309&#x2013;4317. doi: 10.1172/JCI64801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI64801</ArticleId><ArticleId IdType="pmc">PMC3784523</ArticleId><ArticleId IdType="pubmed">24091325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostojic S.M. Tackling guanidinoacetic acid for advanced cellular bioenergetics. Nutrition. 2017;34:55&#x2013;57. doi: 10.1016/j.nut.2016.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2016.09.010</ArticleId><ArticleId IdType="pubmed">28063512</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanese S., Beuchel C.F., Sawall T., Lordick F., Brauer R., Scholz M., Ceglarek U., Hacker U.T. Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients. J.&#xa0;Cachexia Sarcopenia Muscle. 2021;12:2101&#x2013;2110. doi: 10.1002/jcsm.12817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12817</ArticleId><ArticleId IdType="pmc">PMC8718041</ArticleId><ArticleId IdType="pubmed">34636159</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafikov R., Rafikova O., Aggarwal S., Gross C., Sun X., Desai J., Fulton D., Black S.M. Asymmetric dimethylarginine induces endothelial nitric-oxide synthase mitochondrial redistribution through the nitration-mediated activation of Akt1. J.&#xa0;Biol. Chem. 2013;288:6212&#x2013;6226. doi: 10.1074/jbc.M112.423269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.423269</ArticleId><ArticleId IdType="pmc">PMC3585057</ArticleId><ArticleId IdType="pubmed">23255608</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeo F., Eisenberg T., Pietrocola F., Kroemer G. Spermidine in health and disease. Science. 2018;359 doi: 10.1126/science.aan2788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan2788</ArticleId><ArticleId IdType="pubmed">29371440</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit G.Y., Trivieri M.G., Khaper N., Husain T., Wilson G.J., Liu P., Sole M.J., Backx P.H. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation. 2004;109:1877&#x2013;1885. doi: 10.1161/01.CIR.0000124229.40424.80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000124229.40424.80</ArticleId><ArticleId IdType="pubmed">15037530</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnier S., Harakalova M., Weiss S., Mokry M., Regitz-Zagrosek V., Hengstenberg C., Cappola T.P., Isnard R., Arbustini E., Cook S.A., et al. Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23. Eur. Heart J. 2021;42:2000&#x2013;2011. doi: 10.1093/eurheartj/ehab030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab030</ArticleId><ArticleId IdType="pmc">PMC8139853</ArticleId><ArticleId IdType="pubmed">33677556</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Gollapalli K., Mangiola S., Schranner D., Yusuf M.A., Chamoli M., Shi S.L., Lopes Bastos B., Nair T., Riermeier A., et al. Taurine deficiency as a driver of aging. Science. 2023;380 doi: 10.1126/science.abn9257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn9257</ArticleId><ArticleId IdType="pmc">PMC10630957</ArticleId><ArticleId IdType="pubmed">37289866</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuai H., Chan J.F.W., Hu B., Chai Y., Yuen T.T.T., Yin F., Huang X., Yoon C., Hu J.C., Liu H., et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature. 2022;603:693&#x2013;699. doi: 10.1038/s41586-022-04442-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04442-5</ArticleId><ArticleId IdType="pubmed">35062016</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C., Valdes A.M., Polidori L., Antonelli M., Penamakuri S., Nogal A., Louca P., May A., Figueiredo J.C., Hu C., et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399:1618&#x2013;1624. doi: 10.1016/S0140-6736(22)00327-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z., Chong J., Zhou G., de Lima Morais D.A., Chang L., Barrette M., Gauthier C., Jacques P.&#xc9;., Li S., Xia J. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49:W388&#x2013;W396. doi: 10.1093/nar/gkab382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab382</ArticleId><ArticleId IdType="pmc">PMC8265181</ArticleId><ArticleId IdType="pubmed">34019663</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou B., Pache L., Chang M., Khodabakhshi A.H., Tanaseichuk O., Benner C., Chanda S.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1523. doi: 10.1038/s41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson C., Layte R., Jenkinson D., Lawrence K., Petersen S., Paice C., Stradling J. A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies? J.&#xa0;Publ. Health Med. 1997;19:179&#x2013;186. doi: 10.1093/oxfordjournals.pubmed.a024606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.pubmed.a024606</ArticleId><ArticleId IdType="pubmed">9243433</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M., Gudex C., Lloyd A., Janssen M., Kind P., Parkin D., Bonsel G., Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual. Life Res. 2011;20:1727&#x2013;1736. doi: 10.1007/s11136-011-9903-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzyk M.A., Parker C.E., Domanski D., Borchers C.H. Development of MRM-based assays for the absolute quantitation of plasma proteins. Methods Mol. Biol. 2013;1023:53&#x2013;82. doi: 10.1007/978-1-4614-7209-4_4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-7209-4_4</ArticleId><ArticleId IdType="pubmed">23765619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;mer A., Green J., Pollard J., Jr., Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30:523&#x2013;530. doi: 10.1093/bioinformatics/btt703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt703</ArticleId><ArticleId IdType="pmc">PMC3928520</ArticleId><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>